Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
2.
Urology ; 162: 27-32, 2022 04.
Artículo en Inglés | MEDLINE | ID: mdl-34666122

RESUMEN

To address the low numbers of urologists who are ethnically and racially underrepresented in medicine (URiM), the nonprofit organization Urology Unbound developed the R. Frank Jones Urology Interest Group (RFJUIG), a pipeline program that provides mentorship, research opportunities, and professional development for URiM students. Students complete a questionnaire as part of the registration process for the RFJUIG. This questionnaire collects demographic information and asks about their experience pursuing urology and goals for participation in the program. At the end of 2020, 66 students (60% Black and 21% Latinx) were registered members of the RFJUIG. The majority of the members identify as immigrants or first-generation Americans, originating from at least 10 different countries. While most members reported early interest in the field, only 11% had a friend or family with a connection to urology. In the 2021 urology match, 31 of 39 applicant members successfully matched into a urology residency position. Intentional and strategic pipeline programs increase the recruitment of URiMs in urology. Thus far, the RFJUIG successfully provided 79% of its applicant members with the tools needed to successfully match into urology.


Asunto(s)
Estudiantes de Medicina , Urología , Selección de Profesión , Humanos , Mentores , Opinión Pública , Estados Unidos , Urología/educación
3.
J Pediatr Rehabil Med ; 14(4): 655-659, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34864700

RESUMEN

PURPOSE: To characterize common clinical indications for urodynamic, a bladder function test, in adults with spina bifida. METHODS: A retrospective chart review was performed for 215 patients seen in an adult multidisciplinary spina bifida clinic who were registered with the National Spina Bifida Patient Registry from October 2011 to October 2018. Descriptive statistics were used for statistical comparisons. RESULTS: A total of 52 of 215 patients developed a clinical indication for urodynamics. Of these, 71 (33%) patients (8 of whom underwent testing twice) had urodynamics performed, resulting in a total of 79 urodynamic study encounters that were analyzed. Thirty-four (43%) urodynamic testing cases were performed due to a symptomatic change in lower urinary tract function; 14 (18%) were due to declining renal function or concern for upper tract deterioration based on imaging. The data obtained from urodynamic investigation led to new recommendations for urinary tract management in 59 (75%) of the urodynamic studies performed. A total of 32 of the 90 (35%) recommendations made were surgical interventions and 30 (33%) were for a change in medical management. Interestingly, 8 of the 18 (44%) routine or baseline urodynamic tests performed led to new recommendations in urinary tract management. CONCLUSION: A total of 24%of patients in the multidisciplinary spina bifida clinic developed an indication for urodynamic testing over a 7-year period which resulted in new recommendations for urinary tract management in most. As more patients with spina bifida enter adulthood, the indications for urodynamic evaluation may become more defined, since the results often lead to alterations in bladder management.


Asunto(s)
Disrafia Espinal , Vejiga Urinaria Neurogénica , Adulto , Humanos , Estudios Retrospectivos , Disrafia Espinal/complicaciones , Vejiga Urinaria , Vejiga Urinaria Neurogénica/etiología , Vejiga Urinaria Neurogénica/terapia , Urodinámica
5.
Urol Pract ; 10(2): 193, 2023 03.
Artículo en Inglés | MEDLINE | ID: mdl-37103416
7.
Urol Oncol ; 36(2): 60-66, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-28964659

RESUMEN

OBJECTIVE: Prostate cancer is the most common malignancy among males, accounting for 19% of cancers, and the third most common cancer-related cause of death. Suicide rates in the United States have increased among males over the last decade. Further, suicide rates are higher in oncology patients, including patients with prostate cancer, compared to the general population. The objective of this article is to review the current literature and address the relationship between prostate cancer, depression, erectile dysfunction, and suicidal ideation. MATERIALS AND METHODS: We reviewed the current literature pertaining to prostate cancer and depression, and prostate cancer and suicide. Furthermore, associations were made between erectile dysfunction and depression. RESULTS: Men with prostate cancer at increased risk for suicidal death are White, unmarried, elderly, and men with distant disease. Time since diagnosis is also an important factor, since men are at risk of suicide>15 years after diagnosis. Approximately 60% of men with prostate cancer experience mental health distress, with 10%-40% having clinically significant depression. Additionally, patients that received androgen deprivation therapy (ADT) are 23% more likely to develop depression compared to those without ADT. Longitudinal studies of prostate cancer patients suggest that erectile dysfunction after curative treatment may have a significant psychological effect leading to depression. Herein, a newly proposed screening algorithm suggests for an evaluation with the expanded prostate cancer index composite-clinical practice, patient health questionnaire-9, and an 8-question suicidal ideation questionnaire to assess for health-related quality of life, depression, and suicidal ideation. CONCLUSION: The burden of screening for erectile dysfunction, depression and suicidal ideation lies with the entire health care team, as there appears to be an association between these diagnoses, that is, compounded in patients with prostate cancer. The screening algorithm should assist with guiding timely and appropriate psychiatric referral to optimize outcomes in these high-risk patients.


Asunto(s)
Depresión/psicología , Disfunción Eréctil/psicología , Neoplasias de la Próstata/psicología , Ideación Suicida , Suicidio/psicología , Algoritmos , Depresión/complicaciones , Depresión/diagnóstico , Disfunción Eréctil/complicaciones , Disfunción Eréctil/diagnóstico , Encuestas Epidemiológicas , Humanos , Masculino , Neoplasias de la Próstata/complicaciones , Neoplasias de la Próstata/diagnóstico , Factores de Riesgo , Suicidio/estadística & datos numéricos , Prevención del Suicidio
8.
Urology ; 162: 31-32, 2022 04.
Artículo en Inglés | MEDLINE | ID: mdl-35469612
11.
Clin Genitourin Cancer ; 14(3): e251-5, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26428610

RESUMEN

BACKGROUND: Few reports have been published regarding the outcomes of patients who develop an undescended testicular malignancy (UTM). Our objective was to analyze the sociodemographic and survival outcomes of patients with UTM and those of with descended testicular malignancy (DTM). PATIENTS AND METHODS: All 17 registries constituting the Surveillance, Epidemiology, and End Results (SEER) database were analyzed from 1988 to 2008. Patients with a descended or undescended testis and a diagnosis of nonseminomatous or seminomatous testicular cancer were identified. Descriptive statistical data and multivariate analysis were used to identify the predictors of a UTM diagnosis. The primary outcomes were overall and disease-specific survival. RESULTS: The study cohort included 10,159 men (95.3%) with DTM and 496 (4.7%) with UTM. Patients with UTM were more likely to be older, married, and a minority or foreign born and to have seminoma, a higher rate of node positivity, and a higher SEER stage compared with patients with DTM. The median survival time for patients with UTM was longer than that for patients with to DTM (83.1 vs. 72.5 months; P = .0001), although no difference was found in cancer-specific mortality (P = .34). CONCLUSION: Patients with UTM are more likely to be a minority or foreign born, highlighting a previously unrecognized healthcare disparity that might represent a lack of diagnosis and access to care.


Asunto(s)
Criptorquidismo/patología , Hispánicos o Latinos , Grupos Minoritarios , Neoplasias de Células Germinales y Embrionarias/terapia , Neoplasias Testiculares/terapia , Adulto , Criptorquidismo/mortalidad , Disparidades en Atención de Salud , Humanos , Estimación de Kaplan-Meier , Masculino , Neoplasias de Células Germinales y Embrionarias/mortalidad , Neoplasias de Células Germinales y Embrionarias/patología , Programa de VERF , Neoplasias Testiculares/mortalidad , Neoplasias Testiculares/patología , Resultado del Tratamiento , Estados Unidos
13.
Urology ; 99: 252, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27842989
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA